ADIAL PHARMACEUTICALS INC's ticker is ADILW and the CUSIP is 00688A114.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $200 | -84.6% | 35,000 | 0.0% | 0.00% | – |
| Q1 2023 | $1,298 | +29.8% | 35,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,000 | -66.7% | 35,000 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 35,000 | +133.3% | 0.00% | – |
| Q2 2022 | $4,000 | -42.9% | 15,000 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -30.0% | 15,000 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -28.6% | 15,000 | 0.0% | 0.00% | – |
| Q3 2021 | $14,000 | +27.3% | 15,000 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS Group AG | 2 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 4,300 | $3,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 15,000 | $14,000 | 0.00% |